Outlining the pharmacotherapeutic profile and assessment of adherence to treatment in hypertensive and/or diabetic patients: A literature review

• Autor(a) principal: Dantas, Guilherme Cavalcante
• Data de Publicação: 2022
• Outros Autores: Yassin, Ahmed Ali Gomes, Batista, Gabriella Farias, Braga, Victor Mayrink, Monteiro, Ana Karolyne, Nascimento, Aritana Carvalho de Moura, Araújo, Laila Castro, Godoy, Janine Silva Ribeiro, Duarte Junior, Anivaldo Pereira
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/24970
• topic: Doença crônica; Farmacologia clínica; Adesão ao tratamento.; Enfermedad crónica; Farmacología clínica; Adherencia al tratamiento.; Chronic disease; Clinical pharmacology; Treatment adherence.

Chronic diseases (CD) comprise a group of chronic conditions that are generally associated with multiple causes, their onset is gradual and the prognosis is usually uncertain with a long or indefinite duration, which leads the patient to make chronic and often irregular use of the medication. This study aims to understand the pharmacotherapeutic profile of patients with CD and the main factors that influence poor adherence to pharmacological treatment. Data collection was based on studies published in the Scientific Electronic Library Online (SciELO), Pubmed and Academic Google databases using descriptors that most resembled our objectives. The main medications used in the cardiovascular system were angiotensin-converting enzyme inhibitors (ACEI), angiotensin I receptor blockers (ARB), thiazide diuretics and calcium channel blockers (BCC). Of the medications used in glycemic control, the most used were the biguanides followed by the sulfonureas, the prescriptions followed the main guidelines of the Brazilian Society of Cardiology (SBC) and Brazilian Society of Endocrinology and Metabolism (SBEM), however, the use of medications without prescription medica is still a reality that contributes to the appearance of complications and unwanted effects of medications. Finally, it was shown that the understanding of the pharmacotherapeutic profile as well as the factors that influence adherence need to be highlighted and worked on in the best way in order to contribute to therapeutic success and minimize the potential complications of poorly controlled chronic conditions.